CADL earnings
Candel Therapeutics (CADL) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
CADL earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | -0.52 | -0.24 | -118.55% | – |
| Q1 2026 | May 14, 2026 | -0.14 | -0.22 | 36.36% | – |
| Q4 2025 | Mar 12, 2026 | -0.54 | -0.24 | -125.00% | – |
| Q3 2025 | Nov 13, 2025 | -0.21 | -0.17 | -23.53% | – |
| Q2 2025 | Aug 14, 2025 | -0.09 | -0.17 | 47.06% | – |
| Q1 2025 | May 13, 2025 | 0.13 | -0.24 | 154.17% | – |
| Q4 2024 | Mar 13, 2025 | -0.40 | -0.23 | -73.91% | – |
| Q3 2024 | Nov 14, 2024 | -0.33 | – | – | – |
| Q2 2024 | Aug 13, 2024 | -0.74 | – | – | – |
| Q1 2024 | May 14, 2024 | -0.28 | – | – | – |
| Q4 2023 | Mar 28, 2024 | -0.38 | -0.16 | -137.50% | $1.78M |
| Q3 2023 | Nov 9, 2023 | -0.29 | -0.19 | -52.63% | – |
| Q2 2023 | Aug 10, 2023 | -0.33 | -0.23 | -43.48% | – |
| Q1 2023 | May 11, 2023 | -0.30 | -0.35 | 14.29% | – |
| Q4 2022 | Mar 30, 2023 | -0.18 | – | – | $31.00K |
| Q3 2022 | Nov 10, 2022 | -0.30 | – | – | $31.00K |
- CADL reports next on Nov 12, 2026, with EPS of -0.34 expected.
- CADL beat EPS estimates in 4 of its last 11 reports.
Updated 2026-11-10 15:47 UTC